SCHEMBL13458993

SCHEMBL13458993

CCc1cccc(C=O)c1NC=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
MEN1 O00255 1/20 0.38
THRB P10828 1/20 0.38
BLM P54132 1/20 0.38
KMT2A Q03164 1/20 0.38
PIM1 P11309 1/20 0.38
PIM3 Q86V86 1/20 0.38
SCN5A Q14524 4/20 0.38
GABRA1 P14867 2/20 0.38
GABRB2 P47870 2/20 0.38
KCNH2 Q12809 2/20 0.38
CACNA1C Q13936 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 2/20 0.36
ALDH1A1 P00352 2/20 0.36
CLCN2 P51788 1/20 0.36
CYP2C19 P33261 2/20 0.35
ALOX15 P16050 1/20 0.35
HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5533366 0.86 GABRA1 (0.44) LMNATDP1SCN5AGABRA1GABRB2
SCHEMBL15009404 0.83 SCN5A (0.46) LMNATDP1MEN1THRBBLM
SCHEMBL7536495 0.79 PTGS2 (0.46) TDP1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL9801002 0.79 PTGS2 (0.46) TDP1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL14877391 0.78 MEN1 (0.46) LMNATDP1MEN1THRBBLM
SCHEMBL548566 0.76 ALDH1A1 (0.46) LMNATDP1MEN1THRBBLM
SCHEMBL13623166 0.75 ALDH1A1 (0.46) LMNATDP1MEN1THRBBLM
SCHEMBL29002912 0.74 ESR1 (0.39) LMNAMEN1KMT2ASCN5AKCNH2
SCHEMBL29897321 0.73 LMNA (0.57) LMNATDP1MEN1THRBBLM
SCHEMBL224815 0.73 LMNA (0.57) LMNATDP1MEN1THRBBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100063055-A1 CONDENSED TETRAHYDROQUINOLINE DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063055-A1 CONDENSED TETRAHYDROQUINOLINE DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES NR3C2, MC2R, NR5A1 LMNA 3077/4885TDP1 4692/4885MEN1 1211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.